Harbin Pharmaceutical Group Co Ltd (600664) — Cash Flow-to-Debt Ratio
Harbin Pharmaceutical Group Co Ltd (600664) has a Cash Flow-to-Debt Ratio of -0.03x as of September 2025, meaning its operating cash flow of CN¥-192.19 Million could theoretically repay 0% of its total liabilities (CN¥7.67 Billion) in one year. See Harbin Pharmaceutical Group Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Harbin Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2024)
Historical debt coverage capacity for Harbin Pharmaceutical Group Co Ltd across 27 annual periods. For the full cash flow conversion analysis, see 600664 cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year debt coverage analysis for Harbin Pharmaceutical Group Co Ltd. Check Harbin Pharmaceutical Group Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.09x | CN¥792.50 Million | CN¥8.53 Billion | ▼ -15.0% |
| 2023 | 0.11x | CN¥949.67 Million | CN¥8.69 Billion | ▲ +49.1% |
| 2022 | 0.07x | CN¥622.09 Million | CN¥8.48 Billion | ▲ +480.1% |
| 2021 | -0.02x | CN¥-162.44 Million | CN¥8.42 Billion | ▲ +79.2% |
| 2020 | -0.09x | CN¥-728.15 Million | CN¥7.86 Billion | ▼ -113.3% |
| 2019 | -0.04x | CN¥-284.94 Million | CN¥6.56 Billion | ▼ -135.2% |
| 2018 | 0.12x | CN¥692.72 Million | CN¥5.62 Billion | ▲ +413.6% |
| 2017 | 0.02x | CN¥149.22 Million | CN¥6.22 Billion | ▼ -94.2% |
| 2016 | 0.41x | CN¥2.78 Billion | CN¥6.75 Billion | ▲ +55.7% |
| 2015 | 0.26x | CN¥1.66 Billion | CN¥6.28 Billion | ▲ +73.8% |
| 2014 | 0.15x | CN¥1.14 Billion | CN¥7.47 Billion | ▲ +724.6% |
| 2013 | 0.02x | CN¥141.64 Million | CN¥7.68 Billion | ▼ -76.8% |
| 2012 | 0.08x | CN¥557.83 Million | CN¥7.02 Billion | ▲ +1421.6% |
| 2011 | -0.01x | CN¥-31.56 Million | CN¥5.25 Billion | ▼ -102.7% |
| 2010 | 0.22x | CN¥1.15 Billion | CN¥5.22 Billion | ▼ -52.0% |
| 2009 | 0.46x | CN¥1.85 Billion | CN¥4.02 Billion | ▲ +209.8% |
| 2008 | 0.15x | CN¥578.59 Million | CN¥3.89 Billion | ▲ +0.4% |
| 2007 | 0.15x | CN¥650.16 Million | CN¥4.40 Billion | ▼ -11.2% |
| 2006 | 0.17x | CN¥738.08 Million | CN¥4.43 Billion | ▼ -6.8% |
| 2005 | 0.18x | CN¥757.76 Million | CN¥4.24 Billion | ▲ +330.4% |
| 2004 | 0.04x | CN¥149.01 Million | CN¥3.59 Billion | ▼ -52.7% |
| 2003 | 0.09x | CN¥302.83 Million | CN¥3.45 Billion | ▼ -29.6% |
| 2002 | 0.12x | CN¥383.44 Million | CN¥3.08 Billion | ▼ -36.3% |
| 2001 | 0.20x | CN¥604.13 Million | CN¥3.09 Billion | ▲ +2.0% |
| 2000 | 0.19x | CN¥541.70 Million | CN¥2.82 Billion | ▲ +30.7% |
| 1999 | 0.15x | CN¥431.22 Million | CN¥2.94 Billion | ▲ +55.3% |
| 1998 | 0.09x | CN¥221.41 Million | CN¥2.34 Billion | — |